Testing ZP6590 in Men of Various Weights
Part of Hormones & metabolism clinical trials.
This trial tests an experimental medication called ZP6590 given as injections. It's for men who are at a normal weight, overweight, or have obesity, and studies how safe and well-tolerated the drug is in different doses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be male between ages 18 and 60 (depending on the part of the study).
- Your body mass index (BMI) must be between 20 and 39.9, with different ranges for different study parts.
- You must not have used any weight loss pills or treatments in the last 3 months.
- You must be generally healthy with no major blood test abnormalities.
- You must not be taking any medications that the study doctor considers risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.
This study tests an experimental pill (GZC8072) for weight loss. It is a phase 1 trial, meaning it is one of the first times the drug is given to people, and the focus is on safety and how the body handles it. You would receive either a single dose (if you are healthy) or multiple doses (if you are overweight or obese) to see how the medication works.
This study tests how a new diabetes medicine called ZT002 works in the body and whether it interacts safely with other common medications. Researchers will monitor healthy volunteers who are overweight to understand the medicine's safety and effectiveness.
This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
Hear when a new Overweight and Obese Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.